Hernández LMI, Contreras AM

Language: Spanish
References: 11
Page: 3-6
PDF size: 73.63 Kb.

ABSTRACT

The hepatitis C virus (HCV) was identified in 1989 by Houghton et al.1 with cloning techniques of its genome. The HCV infection is a public health problem because it is the main cause of chronic liver disease and death. A proper understanding of the behavior of hepatitis C by medical staff in blood banks is very important; transfusion of blood products means a high risk of transmission of HCV infection before screening tests were available. Currently, there are serological and molecular tests in the Blood Banks, which allow us to identify infected donors, in order to avoid the administration of dangerous blood components and send donors with hepatitis C infection to clinical services for evaluation and antiviral treatment of hepatitis C.

REFERENCES

1. Coo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-64.

2. Méndez-Sánchez N. Epidemiología e impacto social del virus de la hepatitis C. En: Méndez-Sánchez N. Uribe-Esquivel M. Editores Méndez Uribe: Conceptos actuales en hepatitis C. México. Buenos Aires: Ed. McGraw-Hill Interamericana; 2003.

3. Marín-López A. Bancos de Sangre. Consenso de Hepatitis C. Rev Gastroenter 2002; 67(supl.2):11-12.

4. Méndez-Sánchez N. Baptista-González H, Sánchez-Gómez RH, et al. The prevalence of hepatitis B and hepatitis C in blood donors in a 3rd-level hospital of Mexico City. Salud Pública Mex 1999; 41(6):475-8.

5. Norah Terrault. San Francisco California. Hepatitis Viral en los Estados Unidos 2000. NHANES III.

6. Méndez SN, Aguilar RJ, Reyes A, Dehesa M, Juárez A. Castañeda B, Sánchez F, Poo J, González L, Lizardi J, Valdovinos M, Uribe M, Contreras AM. Etiology of liver cirrhosis in Mexico. Ann Hepatol 2004; 3:30-33.

7. Secretaría de Salud. Dirección General de Información en Salud. Elaborado a partir de la base de datos de defunciones, INEGI/Secretaría de Salud.

8. Recomendaciones para la prevención y el control de la infección del virus de la hepatitis C (HCV) y de la enfermedad crónica de HCV. MMWR 1998: 47-5.

9. Muñoz-Espinosa L. Diagnóstico de la infección por el virus de la hepatitis C. Consenso de hepatitis C. Rev Gastroenter 2002; 67(supl.2):13-16.

10. Contreras AM. Anticuerpo a hepatitis C: ¿verdadero o falso positivo? Nuevas estrategias de Diagnóstico. Rev Inv Clin 2006; 58:2,153-160.

11. National Institutes of Health. Consensus Development Conference. Management of hepatitis C. Hepatology 2002; 36(5)Suppl.1: S1-S252.